Timestechpharma

Precision Medicine Market Size to Cross $84 Billion by 2026

Press release   •   Dec 03, 2019 03:23 EST

According to ARC, the global precision medicine market size is expected to be worth around Us$ 84 billion By 2026, jumping 10 percent during 2019 – 2026.

Acumen Research and Consulting’s study on the Precision Medicine Market, offers in-depth information on the growth drivers and restraints impacting the growth of the market. It studies the potential market trajectory between 2019 and 2026. This market analysis report is compiled to help company’s access relevant information.

It reveals hidden growth opportunities for the market players. In addition to this, the report cautions them against possible threat. It therefore covers unparalleled information on the Precision Medicine Market derived from trusted industrial sources. The findings included in the report are backed with relevant graphs and statistics. In addition to this, the report includes expert opinions and statistics from leading international organizations. It uses industry-leading analytical tools to offer accurate predictions on the market, which is the most sought-after by key players as they look to establish a strong foothold in the near future.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1588

The report uses quantitative and qualitative analysis on the information obtained. Based on results obtained, it offers refined growth forecasts for the global Precision Medicine Market. According to the study, the market will witness growth at an accelerated pace in response to the rising demand for novel therapeutics. As a result of increasing prevalence of various illnesses worldwide, governments across the globe are tiring hard and launching several new initiatives to make human resources healthier and fitter than ever. Several countries have ensured access to favourable reimbursement policies, which according to the report, is a chief driver of this market.

In addition to the aforementioned factors, increasing investment towards research and development activities in the pharmaceutical sector is expected to encourage growth in the global market.

Scope of the Report:

The report first uses historic data from different companies. The data collected is used to analyses the growth of industries in the past years. It includes data from the year 2015 to the year 2019. The forecast data provides the reader with an understating of the future of the market. The same data is used to predict the expectation of the companies and how they are expected to evolve in the coming years. The research provides historical as well as estimated data from the year 2019 to 2026. The details in the report give a brief overview of the market by examining its historical data, the current data, and forecast data to understand the growth of the market.

Competitive Landscape

It covers in-depth information on the competitive rivalry witnessed among the leading market players. The report calculates the investment feasibility of this market, which is an indispensable information for potential new entrants. Furthermore, it highlights the most attractive pockets within the global market to help companies plan their investments accordingly. Therefore, for the purpose of the analysis, the report conducts a Porter’s five forces analysis. Through this, it studies the bargaining power suppliers and buyers. The threat to companies from substitutes and new entrants is evaluated as well.

The report dedicates an entire section to discuss the competitive landscape of the market in detail. It studies the growth trajectory of a certain company based on price trend analysis, recent developments, and various other factors.

List of Companies

The report is intended to offer an executive-level blueprint of this market. Therefore, it profiles some of the leading companies operating in the market. Some of the key players in the global Precision Medicine Market include Tepnel Pharma Services, Novartis, Qiagen, Biocrates Life Sciences, NanoString Technologies, Roche, Pfizer, Eagle Genomics, Quest Diagnostics, Menarini Silicon Biosystems, Intomics, and Teva Pharmaceutical and Others. Over the past few years, the companies have increased their production capacity to meet the growing demand. Companies are expected to focus on new product launches and on consolidating their presence in the coming years.

It conducts SWOT Analysis on the companies to gain insights into the strengths and weaknesses of the companies profiled. The analysis also highlighted the most lucrative opportunities for the companies and challenges that could pose threat in the coming years.

The report evaluated the companies and their market positions in terms of growth strategies they adopted over the years and the impact of the same on the overall Precision Medicine Market. Furthermore, the report profiled these companies on the basis of the corporate policies, business collaborations, mergers and acquisitions, product portfolio, and recent launches.

Market Segment Analysis:

Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of the this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of the this market.

Market Segmentation

Market By Technology

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

Market By Application

  • Oncology
  • Immunology
  • CNS
  • Respiratory

Market By End Use

  • Home care
  • Hospitals
  • Clinical Laboratories
  • Others

Market Regional Analysis:

Based on the regions, the global Precision Medicine Market is segmented into -North America (US and Canada), Europe (UK, Germany, France, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific), Latin America (Mexico, Brazil and Rest of Latin America), Middle East & Africa (GCC, South Africa and Rest of MEA)

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Hydraulic Fracturing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Precision Medicine Market By Technology
1.2.2.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Precision Medicine Market Revenue Share By Technology in 2018
1.2.2.3. Big Data Analytics
1.2.2.4. Bioinformatics
1.2.2.5. Gene Sequencing
1.2.2.6. Drug Discovery
1.2.2.7. Companion Diagnostics
1.2.2.8. Others
1.2.3. Precision Medicine Market By Application
1.2.3.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Oncology
1.2.3.3. Immunology
1.2.3.4. CNS
1.2.3.5. Respiratory
1.2.4. Precision Medicine Market By End Use
1.2.4.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Home care
1.2.4.3. Hospitals
1.2.4.4. CBM
1.2.4.5. Clinical Laboratories
1.2.4.6. Others
1.2.5. Precision Medicine Market By Geography
1.2.5.1. Global Precision Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North AmericaPrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.3. EuropePrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-PacificPrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin AmericaPrecision Medicine Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA)Precision Medicine Market Revenueand Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Hydraulic Fracturing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Hydraulic Fracturing Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Hydraulic Fracturing Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Hydraulic Fracturing Major Manufacturers in 2018

CHAPTER 4. PRECISION MEDICINE MARKET BY TECHNOLOGY
4.1. Global Hydraulic Fracturing Revenue By Technology
4.2. Big Data Analytics
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Bioinformatics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Gene Sequencing
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Drug Discovery
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Companion Diagnostics
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. PRECISION MEDICINE MARKET BY APPLICATION
5.1. Global Hydraulic Fracturing Revenue By Application
5.2. Oncology
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Immunology
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. CNS
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Respiratory
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. PRECISION MEDICINE MARKET By End Use
6.1. Global Hydraulic Fracturing Revenue By End Use
6.2. Home care
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Clinical Laboratories
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA PRECISION MEDICINE MARKET BY COUNTRY
7.1. North America Precision Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Precision Medicine Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE PRECISION MEDICINE MARKET BY COUNTRY
8.1. Europe Precision Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC PRECISION MEDICINE MARKET BY COUNTRY
9.1. Asia-Pacific Precision Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA PRECISION MEDICINE MARKET BY COUNTRY
10.1. Latin America Precision Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET BY COUNTRY
11.1. Middle East & Africa Precision Medicine Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Tepnel Pharma Services
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Novartis
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Qiagen
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Biocrates Life Sciences
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. NanoString Technologies
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Roche
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Pfizer
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Eagle Genomics
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Quest Diagnostics
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Menarini Silicon Biosystems
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Intomics
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Teva Pharmaceutical
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Type Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. Others
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Type Portfolio
12.13.5. Key Developments
12.13.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1588

Contact Us:

Acumen Research and Consulting

Email: sales@acumenresearchandconsulting.com

Phone: +1 407 915 4157

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.